Skip to main content

Desensitization

1.Drug desensitization refers to two related concepts. First, desensitization may be equivalent to drug tolerance and refers to subjects' reactions (positive or negative) to a drug reducing following its repeated use. 

2.desensitization, which refers to a biochemical effect where individual receptors become less responsive after repeated application of an agonist. This may be mediated by phosphorylation, for instance by beta adrenoceptor kinase at the beta adrenoceptor.

3.Desensitization is a result of either of continued presence of agonist specific for that receptor (homologous) or of a result of either a class of agonists working toward a “common goal” (heterologous desensitization).

4.There are two known mechanisms for desensitization (see Figure 10.19). a)decrease in response brought about by the covalent modifications produced by receptor phosphorylation and is quite rapid (seconds to minutes).
b)physical removal of receptors from the plasma membrane through a mechanism of receptor-mediated endocytosis and tends to require greater periods (minutes to hours). 

5.Its a very important process whereby cells can decrease their sensitivity to a particular neurotransmitter to prevent saturation of the system. 
Desensitization involves a complex series of events (Kobilka, 1992; Clark et al., 1999; Rosenbaum et al., 2009).
 For GPCRs, functional desensitization is defined as an increase in the concentration of neurotransmitter required to produce half-maximal stimulation of, for example, adenylyl cyclase. In practical terms, desensitization of receptor produces less response for a constant amount of transmitter.

6. How to treat desensitization ?
The procedure most commonly involves initially administering an extremely small amount of a medication (i.e., 1/10,000 of the usual dose). Then, over several hours, gradually increasing doses are given at regular intervals (such as every 15 minutes) until the full dose is reached.

Comments

Popular posts from this blog

review lithium as mood stabilizer

1.Lithium as a mood stabilizer has been used as the standard pharmacological treatment for Bipolar Disorder (BD)   2.Recent studies have also shown that it has the potential for the treatment of many other neurodegenerative disorders, including Alzheimer’s, Parkinson’s and Huntington’s disease, through its neurotrophic, neuroprotective, antioxidant and anti-inflammatory actions. -- Therefore, exploring its pharmacokinetic features and designing better lithium preparations are becoming important research topics.  ---Lithium is rapidly and completely absorbed from the gastrointestinal tract after oral administration. Its level is initially highest in serum and then is evidently redistributed to various tissue compartments. It is not metabolized and over 95% of lithium is excreted unchanged through the kidney, but different lithium preparations may have different pharmacokinetic features. Lithium has a narrow therapeutic window limited by various adverse effects, but some no...

Brain connectivity improves human aesthetic responses to music

Brain connectivity improves human aesthetic responses to music Abstract: 1. white matter connectivity between sensory processing areas in the superior temporal gyrus and emotional and social processing areas in the insula and medial prefrontal cortex explains individual differences in reward sensitivity to music. 2.  findings provide the first evidence for a neural basis of individual differences in sensory access to the reward system, and suggest that social–emotional communication through the auditory channel may offer an evolutionary basis for music making as an aesthetically rewarding function in humans. 3.carried out by -- Using a combination of survey data, behavioral and psychophysiological measures and diffusion tensor imaging, Conclusion: Results from diffusion tensor imaging show that white matter connectivity between auditory perceptual regions (pSTG) and regions of the brain important for emo- tional and social processing (aIns, mPFC) reflect individual diffe...

Drug toxicity of psychotropic drugs

Drug toxicity of psychotropic drugs. Drug toxicity is the development of severe, drug-related complications, which may require premature drug withdrawal or dose reduction. 1. acute toxicity is  highest in.                  antidepressants  lower in neuroleptics   very low in anxiolytics. 2. major problems stem  Anxiolytic ---misuse and overuse. neuroleptics --- tardive dyskinesia is a serious threat to longterm therapy.   antidepressants ---low therapeutic index and a resulting high incidence of severe and fatal poisoning cases, both intentional and accidental. 3.Poisoning death rates per million prescriptions were about 10 times higher for tricyclic antidepressants (TCAs) than for selective serotonin reuptake inhibitors (SSRIs), England and Wales, 1993-2004 4 .Psychotropic drugs with hepatotoxic potential can be classified based on their intended use:  1) antipsychoticsneuroleptics including phenothiazine...